Federated Hermes
SLRN

Federated Hermes’s ACELYRIN SLRN Stock Holding History

Federated Hermes’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,859
Closed -$8.98K – 2188
2024
Q4 		$8.98K Buy
2,859
+2,856
+95,200% +$13.8K ﹤0.01% 1848
2024
Q3 		$15 Sell
3
-5,383
-100% -$27.8K ﹤0.01% 2042
2024
Q2 		$23.8K Buy
+5,386
New +$25.2K ﹤0.01% 1702
2023
Q3 		– Sell
-30,000
Closed -$627K – 2189
2023
Q2 		$627K Buy
+30,000
New +$614K ﹤0.01% 1293

Other funds holding SLRN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $148M AUM 24.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

Federated Hermes's SLRN Position: Q1 2025 in Review

Federated Hermes sold out of ACELYRIN (SLRN) in Q1 2025, closing a stake of 2,859 shares — an estimated $8.98K sold.

Federated Hermes first reported a position in SLRN in Q2 2023 and held it in 4 quarters. The position peaked at $627K in Q2 2023. 105 funds tracked by Wall St. Rank hold SLRN as of Q1 2025.

  • Federated Hermes reported no remaining ACELYRIN position as of Q1 2025 after selling out during the quarter.
  • Federated Hermes sold 2,859 ACELYRIN shares in Q1 2025, an estimated $8.98K.
  • Federated Hermes first reported a position in ACELYRIN in Q2 2023 and held it in 4 quarters.
  • Federated Hermes's ACELYRIN position peaked at $627K in Q2 2023.
  • 105 funds tracked by Wall St. Rank held ACELYRIN as of Q1 2025.

Based on Federated Hermes's 13F filing for Q1 2025, filed 8 May 2025.